Background: Breast cancer is the most common malignant disease in women. The patients with advanced breast cancer develop metastasis to bone. Bone metastasis and skeletal-related events by breast cancer are frequently associated with the invasiveness of breast cancer cells and osteoclasts-mediated bone resorption. Forsythia koreana is used in oriental traditional medicine to treat asthma, atopy, and allergic diseases. The aim of this study was to evaluate the inhibitory effects of F. koreana extracts on the invasion of breast cancer cells and bone resorption by osteoclasts. Methods: Cell viability was measured by an MTT assay and the migration and invasion of MDA-MB-231 cells were detected by a Boyden chamber assay. The formation of osteoclasts and pit was detected using tartrate-resistant acid phosphatase staining and calcium phosphate-coated plates, respectively. The activities of matrix metalloproteinases (MMPs) and cathepsin K were evaluated by gelatin zymography and a cathepsin K detection kit. 
INTRODUCTION
Bone metastasis frequently occurs in patients with metastatic breast cancer. 1 Bone microenvironment is suitable for breast cancer metastasis because of various growth factors in bone matrix such as insulin-like factors, TGF-, fibroblast growth factors, platelet-derived growth factors, and bone morphogenetic proteins. 2, 3 In normal bone, there is balance between osteoclasts which resorb bone and osteoblasts which form bone. Metastatic breast cancer cells secrete osteolytic factors, including parathyroid hormone-related protein, interleukin (IL)-6, IL-8, and IL-11. 4 These factors stimulate osteoblasts or stromal cells to produce receptor activator of nuclear factor kappa-B ligand (RANKL) and inhibit decoy receptor osteoprotegerin. RANKL binds to RANK of osteoclasts precursors and induces osteoclast differentiation, causing bone resorption. 5, 6 The growth factors are released from bone matrix by bone resorption and promote breast cancer cell proliferation and secretion of osteolytic factors. 7, 8 Therefore, osteoclasts, as well as breast cancer cells, can be a strategic therapeutic target for breast cancer patients with bone metastasis. 9, 10 Traditional medicine plants are being considered as promising research materials in drug discovery. 11 Forsythia koreana, a flowering plant in the family Oleaceae, is widely cultivated in South Korea and used to treat inflammatory diseases in Chinese medicine. 12 F. koreana extract has various pharmacological properties including antioxidant, anti-bacterial, and anti-allergic activities. [13] [14] [15] In particular, F. koreana fruit extract inhibits COX-2-mediated prostaglandin E2 production and nitric oxide synthase, indicating anti-inflammatory effects. 16 
Animal
Four-week old male Institute of Cancer Research (ICR) mice were purchased from the Nara Biotech (Pyeongtaek, Korea). The mice were provided free access to a commercial rodent chow and tap water ad libritum, and housed under specific pathogen-free conditions with a 12 hours light/dark cycle at 
Cell cultures
Human mammary carcinoma cell line MDA-MB-231 was obtained from the Korea Cell Line Bank (Seoul, Korea) and the cells were maintained in DMEM supplemented with 10% FBS and 1% antibiotic-antimycotic mixture at 37 o C. Mouse bone marrow-derived macrophages (BMMs) were isolated from tibiae of 4-week-old male ICR mice and cultured in a -MEM containing 10% FBS, 30 ng/mL M-CSF, and 1% antibiotic-antimycotic mixture at 37 o C. All of the cells were incubated in a humidified atmosphere of 5% CO2. 
Cell viability

Cell migration and invasion
Migration assay was performed in 24-well transwell chamber (8 mm pore size; Corning Costar, Cambridge, MA, USA) coated with 10% (w/v) gelatin. Invasion assay was performed using 24-well transwell chamber coated with 10% (w/v) gelatin and 1 mg/mL Matrigel (BD Biosciences, Palo Alto, CA, USA). MDA-MB-231 cells (5 × 10 4 cells/200 L) were incubated in serum-free DMEM containing F. koreana fruit extract at the indicated concentrations and/or TGF-1 (10 ng/mL) in the upper part of a transwell chamber for 6 hours or 24 hours. The lower part of chamber were added with 600 L DMEM containing 5% FBS and F. koreana fruit extract at the indicated concentrations. The migrated or invaded cells to the lower surface of the membrane were fixed with 70% methanol, stained with hematoxylin, and then counted using a Zeiss Axio imager microscope (Zeiss, Oberkochen, Germany).
Osteoclast formation
BMMs ( formaldehyde and stained using the Acid Phosphatase Leukocyte kit (Sigma-Aldrich). The multinucleated tartrate-resistant acid phosphatase-positive cells (≥ 3 nuclei) were counted (× 100, magnification). 
Pit formation
RESULTS
Forsythia koreana extracts inhibited the invasion of MDA-MB-231 human breast cancer cells
We first investigated the effects of F. koreana fruit, branch, and leaf extracts on the viability of MDA-MB-231 metastatic human breast cancer cells. The fruit extract inhibited the cell viability by 15% at 40 g/mL and by 33% at 100 g/mL (Fig. 1A ) but the branch (Fig. 1B) and leaf (Fig. 1C ) extracts did not affect. Next, we found The lower chambers were filled with 600 L of 5% FBS-DMEM containing F. koreana fruit extracts. The cells were incubated for 24 hours. The migrated or invaded cells were fixed, stained, and counted as a described in Materials and Methods. Data are expressed mean ± SE. that F. koreana fruit and leaf extracts significantly reduced the invasion of MDA-MB-231 cells by 48% and 41% at 20 g/mL and 84% and 58% at 40 g/mL, respectively (Fig. 1D ).
Forsythia koreana fruit extract attenuated the TGF-1-induced migration and invasion of MDA-MB-231 cells
TGF-1 plays a critical role in the migration and invasion of breast cancer cells. 21, 22 MMPs are closely associated with cancer invasion and metastasis. 23 The treatment with F. koreana fruit extract decreased the migration (IC50 = 50.6 g/mL; Fig. 2A ) and invasion (IC50 = 22.5 g/mL; Fig. 2B ) of MDA-MB-231 cells by 75% and 92% at 80 g/mL, respectively. TGF-1-induced migration (IC50 = 49.5 g/mL; Fig. 2A ) and invasion (IC50 = 40.9 g/mL; Fig.   2B ) were also reduced by F. koreana fruit extract by 79% and 82%
at 80 g/mL, respectively. In addition, the fruit extract suppressed the proteolytic activities of MMP-2 and MMP-9 in the culture media of MDA-MB-231 cells with or without TGF-1 (Fig. 2C ).
Forsythia koreana extracts blocked the receptor activator of nuclear factor kappa-B ligand-induced osteoclast formation
Bone loss induced by metastasis of breast cancer is caused by excessive osteoclasts. 5 The viability of BMMs as osteoclast precursors was not reduced by the treatment with F. koreana fruit (Fig. 3A) , branch (Fig. 3B) or leaf (Fig. 3C ) extracts for 5 days. RANKL-induced osteoclast formation was significantly decreased by 24%, 58%, and 92% at 10 g/mL and 79%, 95%, and 100% at 20 g/mL of the fruit, branch, and leaf extracts, respectively (Fig. 3D ).
Forsythia koreana extracts suppressed the boneresorbing activity of mature osteoclasts
In bone mimetic material-coated plates, three F. koreana extracts substantially inhibited the formation of osteoclast-mediated resorption pits (Fig. 4A) . In gelatin zymography, F. koreana branch extract suppressed the activities of MMP-2 and MMP-9 derived from RANKL-induced osteoclasts but the fruit and leaf extracts did not show noticeable inhibition (Fig. 4B ). In addition, the cathepsin K activities induced by RANKL stimulation were significantly decreased by the treatment with F. koreana fruit, branch, and leaf extracts by 67%, 80%, and 78% at 40 g/mL, respectively (Fig. 4C) .
DISCUSSION
In the present study to investigate whether F. koreana extracts TGF-1 modulates the homeostasis between MMPs and MMP inhibitors in highly invasive breast cancer cells. 27 In our data, F.
koreana fruit extract, with weak cytotoxic activity but remarkable anti-invasive activity in MDA-MB-231 cells, inhibited TGF-1-induced migration, invasion, and activities of MMP-2 and MMP-9.
These results demonstrate the anti-metastatic potential of F. koreana fruit extract against metastatic breast cancer cells.
In breast cancer patients with bone metastasis, osteoclast formation, and activation were abnormally increased.
2 Several enzymes such as cathepsin K and MMPs were released from mature osteoclasts and these hydrolytic enzymes digest organic components of the bone matrix and promote bone resorption. 28 Thus, many researchers have paid much attention to osteoclast-targeting new agents for the treatment of patients with bone metastasis of breast cancer. 9, 10 Recent studies suggest that breast cancer induced-bone destruction can be prevented by controlling RANKL-induced osteoclast formation and activities of these enzymes. 20, [29] [30] [31] In our study, F. koreana fruit, branch, and leaf extracts did not show cytotoxicity at less than 100 g/mL and significantly inhibited the RANKL-induced formation of osteoclasts and resorption pits at 20 g/mL. Moreover, F. koreana branch extract, rather than the fruit and leaf extracts, substantially inhibited the secreted levels of MMP-2 and MMP-9. Three extracts decreased the release of osteoclast-derived cathepsin K into the culture media. These results indicate that F. koreana extracts may prevent breast cancer-related bone resorption by attenuating RANKL-induced osteoclast formation and activation.
Taken together, F. koreana fruit and leaf extracts have anti-metastatic potential on breast cancer cells and F. koreana extracts have anti-osteoclastogenic and anti-bone-resorbing activities.
Therefore, F. koreana extracts can target both breast cancer cells and osteoclasts, thereby they may be promising agents for prevention of cancer-mediated bone loss and the related skeletal diseases. 
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